MEDVi, a telehealth platform serving more than 100,000 patients, today announced continued nationwide momentum as ...

"Bariatric surgery and GLP-1 receptor agonist medications are currently the most effective weight-loss interventions for ...

People who stop taking GLP-1 drugs such as Ozempic and Wegovy for weight loss are projected to regain their shed pounds ...

People taking the most common GLP-1 drugs lost an average of 33 pounds while on treatment, but gained back about 22 pounds within a year of stopping, study co-author Sam West told The Washington Post.

The health benefits to blood pressure and cholesterol levels also fade after discontinuing the weight-loss medication, ...

A study reveals that weight and health improvements fade within two years after stopping obesity medications, highlighting ...

People who stop taking weight-loss jabs such as Wegovy regain pounds much faster than those who halt exercising and dieting, ...

People taking weight-loss drugs are likely to regain the weight they have lost within two years of stopping the medications, ...

Biomed Industries to Advance NA-931 Into Two Global Phase 3 Trials as Monotherapy and in Combination With Semaglutide and Tirzepatide for Obesity Advancing NA-931 into two Phase 3 programs as ...

People on average regain weight at a rate of 0.4 kg/month after they stopped taking their weight loss medications, a review ...

The new pill will cost $25 or less in copay per month if covered by insurance and between $149 and $299 per month for self-pay.

From the King Kong of weight-loss jabs to the Godzilla of the category, the GLP-1 industry is undergoing big changes ...